{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:39:42Z","timestamp":1759451982497,"version":"build-2065373602"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T00:00:00Z","timestamp":1578873600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Governments of the Republic of Korea, Sweden and India"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.vaccine.2020.01.016","type":"journal-article","created":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T08:06:59Z","timestamp":1579680419000},"page":"A41-A45","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"S1","title":["The history of OCV in India and barriers remaining to programmatic introduction"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0596-8072","authenticated-orcid":false,"given":"Vittal","family":"Mogasale","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suman","family":"Kanungo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanghamitra","family":"Pati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6897-7390","authenticated-orcid":false,"given":"Shanta","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.01.016_b0005","unstructured":"WHO. Cholera. Fact sheet N\u00b0107. Updated October 2016.2015 [cited 2016 3rd June]. Available from: http:\/\/www.who.int\/mediacentre\/factsheets\/fs107\/en\/."},{"issue":"3","key":"10.1016\/j.vaccine.2020.01.016_b0010","first-page":"421","article-title":"Cholera studies. 1. History of the disease","volume":"10","author":"Pollitzer","year":"1954","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2020.01.016_b0015","unstructured":"WHO. Global epidemics and the impact of cholera 2017 [cited 2017 April 1]. Available from: http:\/\/www.who.int\/topics\/cholera\/impact\/en\/."},{"issue":"5","key":"10.1016\/j.vaccine.2020.01.016_b0020","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/2051013614537819","article-title":"Killed oral cholera vaccines: history, development and implementation challenges","volume":"2","author":"Lopez","year":"2014","journal-title":"Therapeutic Adv Vaccines"},{"issue":"7365","key":"10.1016\/j.vaccine.2020.01.016_b0025","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/nature10392","article-title":"Evidence for several waves of global transmission in the seventh cholera pandemic","volume":"477","author":"Mutreja","year":"2011","journal-title":"Nature"},{"issue":"6364","key":"10.1016\/j.vaccine.2020.01.016_b0030","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1126\/science.aad5901","article-title":"Genomic history of the seventh pandemic of cholera in Africa","volume":"358","author":"Weill","year":"2017","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.vaccine.2020.01.016_b0035","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1093\/trstmh\/trv057","article-title":"Role of phytoplankton in maintaining endemicity and seasonality of cholera in Bangladesh","volume":"109","author":"Islam","year":"2015","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"24","key":"10.1016\/j.vaccine.2020.01.016_b0040","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.1016\/j.vaccine.2017.09.034","article-title":"Cholera vaccine: WHO position paper, August 2017 - Recommendations","volume":"36","author":"World Health O","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.01.016_b0045","unstructured":"WHO. Oral cholera vaccines2019 [cited 2019 6 October]. Available from: https:\/\/www.who.int\/cholera\/vaccines\/en\/."},{"key":"10.1016\/j.vaccine.2020.01.016_b0050","unstructured":"WHO. The Global Task Force on Cholera Control2019 [cited 2019 6, October]. Available from: https:\/\/www.who.int\/cholera\/task_force\/en\/."},{"key":"10.1016\/j.vaccine.2020.01.016_b0055","unstructured":"WHO. Ending Cholera: A Global Roadmap to 2030 2019 [cited 2019 October 6]. Available from: https:\/\/www.who.int\/cholera\/publications\/global-roadmap\/en\/."},{"issue":"suppl_3","key":"10.1016\/j.vaccine.2020.01.016_b0060","doi-asserted-by":"crossref","first-page":"S137","DOI":"10.1093\/infdis\/jiy486","article-title":"Partners of the Global Task Force on Cholera C. Global Cholera Epidemiology: Opportunities to Reduce the Burden of Cholera by 2030","volume":"218","author":"Legros","year":"2018","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2020.01.016_b0065","first-page":"491","article-title":"A brief history of vaccines & vaccination in India","volume":"139","author":"Lahariya","year":"2014","journal-title":"Indian J Med Res"},{"issue":"5","key":"10.1016\/j.vaccine.2020.01.016_b0070","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1586\/14760584.7.5.561","article-title":"Vaccination with Dukoral against travelers' diarrhea (ETEC) and cholera","volume":"7","author":"Jelinek","year":"2008","journal-title":"Expert Rev Vaccines"},{"issue":"11","key":"10.1016\/j.vaccine.2020.01.016_b0075","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1093\/cid\/cir141","article-title":"Oral vaccines against cholera","volume":"52","author":"Shin","year":"2011","journal-title":"Clin Infect Diseases: Off Publ Infect Diseases Soc Am"},{"issue":"12","key":"10.1016\/j.vaccine.2020.01.016_b0080","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/S1473-3099(13)70273-1","article-title":"5 year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: a cluster-randomised, double-blind, placebo-controlled trial","volume":"13","author":"Bhattacharya","year":"2013","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2020.01.016_b0085","doi-asserted-by":"crossref","first-page":"e2323","DOI":"10.1371\/journal.pone.0002323","article-title":"A randomized, placebo-controlled trial of the bivalent killed, whole-cell, oral cholera vaccine in adults and children in a cholera endemic area in Kolkata, India","volume":"3","author":"Mahalanabis","year":"2008","journal-title":"PLoS ONE"},{"issue":"49","key":"10.1016\/j.vaccine.2020.01.016_b0090","doi-asserted-by":"crossref","first-page":"6887","DOI":"10.1016\/j.vaccine.2009.09.008","article-title":"Immune responses following one and two doses of the reformulated, bivalent, killed, whole-cell, oral cholera vaccine among adults and children in Kolkata, India: a randomized, placebo-controlled trial","volume":"27","author":"Kanungo","year":"2009","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2020.01.016_b0095","doi-asserted-by":"crossref","first-page":"e1001712","DOI":"10.1371\/journal.pmed.1001712","article-title":"Oral cholera vaccine development and use in Vietnam","volume":"11","author":"Anh","year":"2014","journal-title":"PLoS Med"},{"issue":"6","key":"10.1016\/j.vaccine.2020.01.016_b0100","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.vaccine.2006.09.049","article-title":"Safety and immunogenicity of a reformulated Vietnamese bivalent killed, whole-cell, oral cholera vaccine in adults","volume":"25","author":"Anh","year":"2007","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2020.01.016_b0105","doi-asserted-by":"crossref","first-page":"e1002120","DOI":"10.1371\/journal.pmed.1002120","article-title":"Potential for controlling cholera using a ring vaccination strategy: re-analysis of data from a cluster-randomized clinical trial","volume":"13","author":"Ali","year":"2016","journal-title":"PLoS Med"},{"issue":"8","key":"10.1016\/j.vaccine.2020.01.016_b0110","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1093\/cid\/cit009","article-title":"Herd protection by a bivalent killed whole-cell oral cholera vaccine in the slums of Kolkata, India","volume":"56","author":"Ali","year":"2013","journal-title":"Clin Infect Diseases: Off Publ Infect Diseases Soc Am"},{"issue":"2","key":"10.1016\/j.vaccine.2020.01.016_b0115","doi-asserted-by":"crossref","first-page":"e2629","DOI":"10.1371\/journal.pntd.0002629","article-title":"Mass vaccination with a new, less expensive oral cholera vaccine using public health infrastructure in India: the Odisha model","volume":"8","author":"Kar","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2020.01.016_b0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005124","article-title":"Oral Cholera vaccination delivery cost in low- and middle-income countries: an analysis based on systematic review","volume":"10","author":"Mogasale","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2020.01.016_b0125","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1080\/21645515.2018.1460295","article-title":"Feasibility and costs of a targeted cholera vaccination campaign in Ethiopia","volume":"14","author":"Teshome","year":"2018","journal-title":"Human Vaccines Immunotherap"},{"issue":"9","key":"10.1016\/j.vaccine.2020.01.016_b0130","doi-asserted-by":"crossref","first-page":"e0004072","DOI":"10.1371\/journal.pntd.0004072","article-title":"An estimation of private household costs to receive free oral cholera vaccine in Odisha, India","volume":"9","author":"Mogasale","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2020.01.016_b0135","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.4161\/21645515.2014.971655","article-title":"Uptake during an oral cholera vaccine pilot demonstration program, Odisha, India","volume":"10","author":"Kar","year":"2014","journal-title":"Human Vaccines Immunotherap"},{"issue":"21","key":"10.1016\/j.vaccine.2020.01.016_b0140","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1016\/j.vaccine.2015.03.073","article-title":"Effectiveness of an oral cholera vaccine campaign to prevent clinically-significant cholera in Odisha State, India","volume":"33","author":"Wierzba","year":"2015","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2020.01.016_b0145","doi-asserted-by":"crossref","first-page":"e223","DOI":"10.1016\/S2214-109X(16)00037-1","article-title":"A second affordable oral cholera vaccine: implications for the global vaccine stockpile","volume":"4","author":"Desai","year":"2016","journal-title":"Lancet Global Health"},{"issue":"3","key":"10.1016\/j.vaccine.2020.01.016_b0150","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1080\/21645515.2016.1245250","article-title":"Achievements and challenges for the use of killed oral cholera vaccines in the global stockpile era","volume":"13","author":"Desai","year":"2017","journal-title":"Human Vaccines Immunotherap"},{"key":"10.1016\/j.vaccine.2020.01.016_b0155","first-page":"246","article-title":"How endemic is cholera in India?","volume":"135","author":"Sarkar","year":"2012","journal-title":"Indian J Med Res"},{"issue":"11","key":"10.1016\/j.vaccine.2020.01.016_b0160","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1136\/adc.2004.071316","article-title":"The burden of cholera in the slums of Kolkata, India: data from a prospective, community based study","volume":"90","author":"Sur","year":"2005","journal-title":"Arch Dis Child"},{"issue":"3","key":"10.1016\/j.vaccine.2020.01.016_b0165","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2471\/BLT.09.073460","article-title":"Cholera in India: an analysis of reports, 1997\u20132006","volume":"88","author":"Kanungo","year":"2010","journal-title":"Bull World Health Organ"},{"issue":"6","key":"10.1016\/j.vaccine.2020.01.016_b0170","doi-asserted-by":"crossref","first-page":"e0003832","DOI":"10.1371\/journal.pntd.0003832","article-title":"Updated global burden of cholera in endemic countries","volume":"9","author":"Ali","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2020.01.016_b0175","doi-asserted-by":"crossref","first-page":"e0183100","DOI":"10.1371\/journal.pone.0183100","article-title":"Identification of burden hotspots and risk factors for cholera in India: An observational study","volume":"12","author":"Ali","year":"2017","journal-title":"PLoS ONE"},{"issue":"480","key":"10.1016\/j.vaccine.2020.01.016_b0180","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau6242","article-title":"Estimating cholera incidence with cross-sectional serology","volume":"11","author":"Azman","year":"2019","journal-title":"Sci Transl Med"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2020.01.016_b0185","doi-asserted-by":"crossref","first-page":"A88","DOI":"10.1016\/j.vaccine.2010.02.041","article-title":"India's National Technical Advisory Group on Immunisation","volume":"28","author":"John","year":"2010","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2020.01.016_b0190","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1017\/S0950268811000513","article-title":"Costs of illness due to endemic cholera","volume":"140","author":"Poulos","year":"2012","journal-title":"Epidemiol Infect"},{"issue":"S1","key":"10.1016\/j.vaccine.2020.01.016_b0195","doi-asserted-by":"crossref","first-page":"A160","DOI":"10.1016\/j.vaccine.2019.09.099","article-title":"Economic burden of cholera in Asia","volume":"38","author":"Mogasale","year":"2020","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2020.01.016_b0200","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/S1473-3099(17)30352-3","article-title":"Cholera in Yemen","volume":"17","author":"Balakrishnan","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"6345","key":"10.1016\/j.vaccine.2020.01.016_b0205","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1126\/science.356.6345.1316","article-title":"Cholera vaccine faces major test in Yemen","volume":"356","author":"Kupferschmidt","year":"2017","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.vaccine.2020.01.016_b0210","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1056\/NEJMp1614104","article-title":"Eliminating Cholera Transmission in Haiti","volume":"376","author":"Ivers","year":"2017","journal-title":"New Engl J Med"},{"issue":"3","key":"10.1016\/j.vaccine.2020.01.016_b0215","doi-asserted-by":"crossref","first-page":"e162","DOI":"10.1016\/S2214-109X(14)70368-7","article-title":"Effectiveness of reactive oral cholera vaccination in rural Haiti: a case-control study and bias-indicator analysis","volume":"3","author":"Ivers","year":"2015","journal-title":"Lancet Global Health"},{"issue":"5","key":"10.1016\/j.vaccine.2020.01.016_b0220","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.4269\/ajtmh.15-0700","article-title":"Effectiveness of Oral Cholera Vaccine in Haiti: 37-Month Follow-Up","volume":"94","author":"Severe","year":"2016","journal-title":"Am J Trop Med Hygiene"},{"issue":"24","key":"10.1016\/j.vaccine.2020.01.016_b0225","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.1016\/j.vaccine.2017.09.034","article-title":"vaccine: WHO position paper, August 2017 - Recommendations","volume":"36","author":"Cholera","year":"2018","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2020.01.016_b0230","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/14760584.2017.1249470","article-title":"Improving immunization approaches to cholera","volume":"16","author":"Saha","year":"2017","journal-title":"Expert Rev Vaccines"},{"issue":"6","key":"10.1016\/j.vaccine.2020.01.016_b0235","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s13312-017-1044-z","article-title":"Pneumococcal Conjugate Vaccine Introduction in India's Universal Immunization Program","volume":"54","author":"Sachdeva","year":"2017","journal-title":"Indian Pediatr"},{"issue":"S1","key":"10.1016\/j.vaccine.2020.01.016_b0240","doi-asserted-by":"crossref","first-page":"A148","DOI":"10.1016\/j.vaccine.2019.07.029","article-title":"Preventing cholera in India: Synthesizing evidences through a systematic review for policy discussion on the use of oral cholera vaccine","volume":"38","author":"Panda","year":"2020","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2020.01.016_b0245","article-title":"Oral cholera vaccines to control endemic disease: an economic and epidemiological modelling analysis","volume":"382","author":"Mogasale","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2020.01.016_b0250","unstructured":"Ann Levin DD, Kim YE, Clemens J, Lopez AL, Ali M, Burgess C, Shin S, Wierzba T. An Investment Case for the Accelerated Introduction of Oral Cholera Vaccines. Seoul, South Korea; 2012."},{"key":"10.1016\/j.vaccine.2020.01.016_b0255","unstructured":"Lopez AL, DeRoeck D, Maskery B, Levin A, Bultman J, Kim YE. Country Investment Case Study on Cholera Vaccination: Bangladesh. IVI, Seoul, South Korea; 2012."},{"issue":"6","key":"10.1016\/j.vaccine.2020.01.016_b0260","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/j.1524-4733.2009.00562.x","article-title":"Group DCES. Cost-effectiveness of new-generation oral cholera vaccines: a multisite analysis","volume":"12","author":"Jeuland","year":"2009","journal-title":"Value Health: J Int Soc Pharmacoecon Outcomes Res"},{"issue":"18","key":"10.1016\/j.vaccine.2020.01.016_b0265","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/j.vaccine.2016.03.004","article-title":"Impact of oral cholera vaccines in cholera-endemic countries: A mathematical modeling study","volume":"34","author":"Kim","year":"2016","journal-title":"Vaccine"},{"issue":"52","key":"10.1016\/j.vaccine.2020.01.016_b0270","doi-asserted-by":"crossref","first-page":"7033","DOI":"10.1016\/j.vaccine.2014.05.028","article-title":"Considerations around the introduction of a cholera vaccine in Bangladesh","volume":"32","author":"Nelson","year":"2014","journal-title":"Vaccine"},{"issue":"S1","key":"10.1016\/j.vaccine.2020.01.016_b0275","doi-asserted-by":"crossref","first-page":"A175","DOI":"10.1016\/j.vaccine.2019.06.047","article-title":"Programmatic Preparations and challenges for OCV introduction in India","volume":"38","author":"Haldar","year":"2020","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20300311?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20300311?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:39:23Z","timestamp":1759401563000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20300311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":55,"alternative-id":["S0264410X20300311"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.01.016","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The history of OCV in India and barriers remaining to programmatic introduction","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.01.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}